Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

Dupixent has been approved for CSU in Japan and the United Arab Emirates (UAE) and is also under regulatory review in the EU based on earlier study readouts. Outside of Japan and the UAE, the safety ...

The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...

Hive Blockchain Technologies Ltd ( (HIVE) ) has released its Q2 earnings. Here is a breakdown of the information Hive Blockchain Technologies ...

While HIVE Digital Technologies has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key ...

The hashrate growth profile for the firm remains strong as it has begun construction of its new 100 MW facility in Paraguay, ...

By Bertus Bierman South Africa faces immense challenges in developing and maintaining the infrastructure it needs to support ...

but also what knock-on implications this may have on the wider environment because bees play such a key role as a pollinator.

HIVE Digital Technologies (HIVE) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.29 per share a year ago. These ...

If you’re hesitant about spending $59.99 on Stalker 2: Heart of Chornobyl, you’ll be pleased to know that the game is ...

Hive Autonomy, a Norwegian leader in autonomous technology, has become the factory’s first customer, using Telenor’s ...